Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc > New 5 minutes test for COVID-19 by Abott

<< Previous

Bullboard Posts

Next >>

Comment by EduardoSanchezon Mar 29, 2020 10:42am

107 Views

Post# 30857329

RE:RE:RE:New 5 minutes test for COVID-19 by Abott

The Abbott 5 minute PCR test is far from a sensitive test. It is achieves below 90% concordance. This type of test is generally used for diagnosing the flu which makes sense, but to diagnose Covid which is 20 X more lethal makes no sense. This test will not contain Covid. It goes to show how desperate the US is to get rapid testing.

Here is an article from Science Daily showing results of a study that shows RT PCR is diagnosing Covid at 71%. That is scary. This last thing we need is a less sensitive RT PCR. Lexagene is over 99% concordance and amplified DNA over a trillion fold to achieve gold standard lab quality results. We don't need to be cutting corners and rushing any RT PCR test out as this will not help contain Covid

Chest CT, a routine imaging tool for pneumonia diagnosis, is fast and relatively easy to perform. Recent research found that the sensitivity of CT for COVID-19 infection was 98% compared to RT-PCR
71%
https://www.sciencedaily.com/releases/2020/02/200226151951.htm